Summary: Major Depressive Disorder (MDD) varies widely between people, and standard first-line treatments such as selective serotonin reuptake inhibitors (SSRIs) fail to adequately help a large proportion of patients. A recent study demonstrates a precision psychiatry approach using real-time fMRI neurofeedback to target the specific brain circuit that drives rumination, producing measurable reductions in depressive symptoms.
This research uses individualised neural targeting: instead of a one-size-fits-all intervention, clinicians identify the dysfunctional circuit underlying a patient’s dominant symptom and train the brain to shift toward healthier connectivity. The team applied this strategy to rumination, the repetitive negative self-focused thinking that is a defining feature of many depressive episodes.
Key Research Findings
- The Target Circuit: The study focused on the functional coupling between the posterior cingulate cortex (PCC), a hub of self-referential and internally directed thought, and the dorsolateral prefrontal cortex (DLPFC), which supports goal-directed and externally focused cognition.
- Gamified Neurofeedback: Participants trained inside an MRI scanner using a simple visual feedback game: a green circle on a screen grew larger as their brain connectivity became more similar to healthy patterns.
- Optimal Training Conditions: Training on consecutive days and offering larger external rewards produced the strongest neural improvements.
- Lasting Neural Shifts: The healthier connectivity patterns persisted into resting-state scans, indicating durable change rather than only short-lived, task-bound effects.
- Symptom Specificity: Improvements in PCC–DLPFC connectivity correlated with reductions in rumination and depressive symptoms, but not with anxiety, demonstrating circuit-specific therapeutic effects.
Source: ATR
Why this matters
MDD is not a uniform condition. Individuals present different symptom clusters that reflect distinct underlying neural disturbances. Yet most patients receive similar pharmacological treatments despite this heterogeneity. The mismatch between symptom origins and standard treatment helps explain why roughly 30–50% of people with MDD do not achieve full remission with conventional approaches.
Precision psychiatry aims to close that gap by tailoring interventions to the neural circuit driving the problematic symptom. In this study, rumination was chosen as an initial target because it is a central mechanism in many depressive episodes and is associated with altered connectivity between the brain’s default-mode network (including PCC) and executive-control regions (including DLPFC).
Using real-time functional connectivity neurofeedback (FCNef), the research team provided participants with an immediate visual representation of whether their brain activity was moving toward the target connectivity pattern. Participants experimented with mental strategies—mental arithmetic, word associations, visualizations, and other approaches—to discover what reliably changed the feedback signal. The process resembles a biofeedback-based video game, where the player learns which internal actions influence the display.
The study included 68 participants and deliberately varied training parameters to identify protocols that maximize benefit. Specifically, the researchers compared sessions scheduled on consecutive days versus spread across time, and they manipulated the size of external monetary incentives. Participants who trained on consecutive days with higher potential earnings achieved the largest improvements in neural connectivity.
Beyond the immediate target, the intervention also reduced connectivity between the broader Executive Control and Default Mode networks, indicating the effect extended to large-scale systems rather than remaining confined to two isolated regions. Importantly, the neural changes translated to clinically relevant outcomes: participants whose connectivity shifted toward the healthy pattern experienced greater reductions in rumination and depressive symptoms. Anxiety scores, which the intervention did not target, remained unchanged—supporting the specificity of the approach.
Key Questions Answered:
A: The setup functions as a biofeedback loop. Real-time processing translates functional connectivity into a visual cue; participants try different mental strategies—math, word games, imagery—to see which thoughts enlarge the on-screen circle. The display provides immediate feedback on how well their brain state matches the desired pattern.
A: Rumination is a pervasive, self-reinforcing pattern of negative thought strongly linked to depression. By normalising the neural interactions that support this loop—particularly between PCC and DLPFC—researchers can directly reduce a core depressive symptom that medication alone may not adequately address.
A: The long-term aim is to translate MRI-derived targets into portable, scalable tools such as EEG-based headsets. Those devices could deliver targeted neurofeedback at home after an initial assessment identifies the patient’s symptom-specific neural signature.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by editorial staff.
About this neurotech and depression research news
Author: Ritsuko Mashimo
Source: ATR
Contact: Ritsuko Mashimo – ATR
Image: Image credit: Neuroscience News
Original Research: Open access. “Paving the way for precision treatment of psychiatric symptoms with functional connectivity neurofeedback” by J. E. Taylor et al., published in Translational Psychiatry. DOI: 10.1038/s41398-026-04040-3.
Abstract
Paving the way for precision treatment of psychiatric symptoms with functional connectivity neurofeedback
Treatment for Major Depressive Disorder often remains uniform despite patients presenting diverse symptom profiles that reflect distinct neural disruptions. Demonstrating a more individualised approach, this research shows that normalising a specific neural network via real-time fMRI functional connectivity neurofeedback (FCNef) can reduce related symptoms. The team previously found that normalising connectivity between dorsolateral prefrontal cortex (DLPFC) and posterior cingulate cortex/precuneus (PCC) reduced brooding rumination but not anxiety.
To test robustness and optimise parameters, the researchers extended their protocol to a larger cohort (final N = 68). They replicated earlier findings, demonstrating that FCNef reliably shifts targeted connectivity and that these shifts are specific to rumination symptoms. For the first time they also observed decreased connectivity between the broader Executive Control and Default Mode networks. Parameter tests showed that consecutive-day training combined with greater external reward produced the strongest effects.
These results support the potential of FCNef as a precision tool in psychiatry and highlight the need to refine training protocols to increase feasibility for real-world, BMI-based clinical interventions.